Behavioral and neurochemical studies of inherited manganese-induced dystonia-parkinsonism in Slc39a14-knockout mice

[1]  C. Janus,et al.  Phenotypic evaluation of a childhood-onset parkinsonism-dystonia mouse model with inherent postural abnormalities , 2020, Brain Research Bulletin.

[2]  A. Lees,et al.  Neuropathological Findings in Ephedrone Encephalopathy , 2020, Movement disorders : official journal of the Movement Disorder Society.

[3]  M. Aschner,et al.  Maintaining Translational Relevance in Animal Models of Manganese Neurotoxicity. , 2020, The Journal of nutrition.

[4]  Xiaotang Fan,et al.  Abnormal Cerebellar Development Is Involved in Dystonia-Like Behaviors and Motor Dysfunction of Autistic BTBR Mice , 2019, Frontiers in Cell and Developmental Biology.

[5]  J. Volkmann,et al.  Striatal dopaminergic dysregulation and dystonia-like movements induced by sensorimotor stress in a pharmacological mouse model of rapid-onset dystonia-parkinsonism , 2019, Experimental Neurology.

[6]  D. Standaert,et al.  Diverse Mechanisms Lead to Common Dysfunction of Striatal Cholinergic Interneurons in Distinct Genetic Mouse Models of Dystonia , 2019, The Journal of Neuroscience.

[7]  T. Guilarte,et al.  PET imaging of dopamine release in the frontal cortex of manganese‐exposed non‐human primates , 2019, Journal of neurochemistry.

[8]  Wei Liu,et al.  Alpha-Synuclein and Calpains Disrupt SNARE-Mediated Synaptic Vesicle Fusion During Manganese Exposure in SH-SY5Y Cells , 2018, Cells.

[9]  Adel M. Zeglam,et al.  Autosomal-recessive iron deficiency anemia, dystonia and hypermanganesemia caused by new variant mutation of the manganese transporter gene SLC39A14 , 2018, Acta Neurologica Belgica.

[10]  A. Woolf,et al.  Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies. , 2018, Molecular genetics and metabolism.

[11]  M. Faruq,et al.  A novel mutation in SLC39A14 causing hypermanganesemia associated with infantile onset dystonia , 2018, The journal of gene medicine.

[12]  R. Weiskirchen,et al.  SLC39A14 deficiency alters manganese homeostasis and excretion resulting in brain manganese accumulation and motor deficits in mice , 2018, Proceedings of the National Academy of Sciences.

[13]  R. Artuch,et al.  Hypermanganesemia due to mutations in SLC39A14: further insights into Mn deposition in the central nervous system , 2018, Orphanet Journal of Rare Diseases.

[14]  K. Khodakhah,et al.  It's not just the basal ganglia: Cerebellum as a target for dystonia therapeutics , 2017, Movement disorders : official journal of the Movement Disorder Society.

[15]  S. Mukhopadhyay.  Familial manganese-induced neurotoxicity due to mutations in SLC30A10 or SLC39A14. , 2017, Neurotoxicology.

[16]  Yingying Yu,et al.  Manganese transporter Slc39a14 deficiency revealed its key role in maintaining manganese homeostasis in mice , 2017, Cell Discovery.

[17]  M. Febo,et al.  Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity , 2017, The Journal of Neuroscience.

[18]  Andreea C. Bostan,et al.  Current Opinions and Areas of Consensus on the Role of the Cerebellum in Dystonia , 2017, The Cerebellum.

[19]  Wei Liu,et al.  Manganese exposure disrupts SNARE protein complex‐mediated vesicle fusion in primary cultured neurons , 2017, Environmental toxicology.

[20]  Stephen W. Wilson,et al.  Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia , 2016, Nature Communications.

[21]  T. Guilarte,et al.  TSPO in a murine model of Sandhoff disease: presymptomatic marker of neurodegeneration and disease pathophysiology , 2016, Neurobiology of Disease.

[22]  K. Simon,et al.  Manganese Encephalopathy among Ephedron Abusers‐Case Reports , 2015, Journal of Neuroimaging.

[23]  T. Guilarte,et al.  Manganese-Induced Parkinsonism Is Not Idiopathic Parkinson's Disease: Environmental and Genetic Evidence. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  W. Dauer,et al.  TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration. , 2014, The Journal of clinical investigation.

[25]  H. Sienkiewicz-Jarosz,et al.  MRI brain findings in ephedrone encephalopathy associated with manganese abuse: Single-center perspective , 2014, Polish journal of radiology.

[26]  Philip A. Huebner,et al.  Pathology of inherited manganese transporter deficiency , 2014, Annals of neurology.

[27]  B. Majkowska-Zwolińska,et al.  Manganese-induced Parkinsonism among ephedrone users and drug policy in Poland. , 2013, Journal of addiction medicine.

[28]  S. Aquilonius,et al.  Manganese‐induced parkinsonism in methcathinone abusers: bio‐markers of exposure and follow‐up , 2013, European journal of neurology.

[29]  T. Guilarte.  Manganese neurotoxicity: new perspectives from behavioral, neuroimaging, and neuropathological studies in humans and non-human primates , 2013, Front. Aging Neurosci..

[30]  H. Jinnah,et al.  Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia , 2012, Neurobiology of Disease.

[31]  A. Burroughs,et al.  Dystonia with Brain Manganese Accumulation Resulting From SLC30A10 Mutations: A New Treatable Disorder , 2012, Movement disorders : official journal of the Movement Disorder Society.

[32]  R. Cousins,et al.  The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice. , 2012, Gastroenterology.

[33]  B. Oostra,et al.  Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. , 2012, American journal of human genetics.

[34]  R. Wevers,et al.  Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. , 2012, American journal of human genetics.

[35]  J. Redmond,et al.  Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report , 2012, Journal of Medical Case Reports.

[36]  Madiha Khalid,et al.  Altered striatal dopamine release following a sub-acute exposure to manganese , 2011, Journal of Neuroscience Methods.

[37]  K. Gordon,et al.  Manganese Toxicity in a Child With Iron Deficiency and Polycythemia , 2011, Journal of child neurology.

[38]  F. Barbosa,et al.  A Simple Method Based on ICP-MS for Estimation of Background Levels of Arsenic, Cadmium, Copper, Manganese, Nickel, Lead, and Selenium in Blood of the Brazilian Population , 2010, Journal of toxicology and environmental health. Part A.

[39]  Tomás R. Guilarte,et al.  Manganese and Parkinson’s Disease: A Critical Review and New Findings , 2010, Environmental health perspectives.

[40]  L. Thurfjell,et al.  Clinical, neuroimaging and neurophysiological features in addicts with manganese‐ephedrone exposure , 2010, Acta neurologica Scandinavica.

[41]  D. Standaert,et al.  Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo , 2010, Journal of neurochemistry.

[42]  C. Colosimo,et al.  Parkinsonism due to ephedrone neurotoxicity: a case report , 2009, European journal of neurology.

[43]  E. Fisher,et al.  A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice , 2009, Proceedings of the National Academy of Sciences.

[44]  L. Pham,et al.  Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism(s): implications to manganese‐induced parkinsonism , 2008, Journal of neurochemistry.

[45]  A. Lees,et al.  Parkinsonism and dystonia caused by the illicit use of ephedrone—A longitudinal study , 2008, Movement disorders : official journal of the Movement Disorder Society.

[46]  G. Palù,et al.  The Mouse Brain , 2008, Neurobiology of Disease.

[47]  M. Bitner-Glindzicz,et al.  Hepatic cirrhosis, dystonia, polycythaemia and hypermanganesaemia—A new metabolic disorder , 2008, Journal of Inherited Metabolic Disease.

[48]  A. Stepens,et al.  A Parkinsonian syndrome in methcathinone users and the role of manganese. , 2008, The New England journal of medicine.

[49]  Vanita Sahni,et al.  Case Report: A Metabolic Disorder Presenting as Pediatric Manganism , 2007, Environmental health perspectives.

[50]  X. Breakefield,et al.  Dopamine release is impaired in a mouse model of DYT1 dystonia , 2007, Journal of neurochemistry.

[51]  S. Fahn,et al.  Manganic encephalopathy due to “ephedrone” abuse , 2007, Movement disorders : official journal of the Movement Disorder Society.

[52]  Antonio P Strafella,et al.  Manganese-induced Parkinsonism associated with methcathinone (Ephedrone) abuse. , 2007, Archives of neurology.

[53]  J. Bergquist,et al.  Irreversible motor impairment in young addicts – ephedrone, manganism or both? , 2007, Acta neurologica Scandinavica.

[54]  Hasan Meral,et al.  Parkinsonism Caused by Chronic Usage of Intravenous Potassium Permanganate , 2007, The neurologist.

[55]  T. Guilarte,et al.  Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates , 2006, Experimental Neurology.

[56]  M. West,et al.  Estimators of the precision of stereological estimates: An example based on the CA1 pyramidal cell layer of rats , 2005, Neuroscience.

[57]  Michael Aschner,et al.  Nutritional aspects of manganese homeostasis. , 2005, Molecular aspects of medicine.

[58]  C. Sherwood,et al.  Is humanlike cytoarchitectural asymmetry present in another species with complex social vocalization? A stereologic analysis of mustached bat auditory cortex , 2005, Brain Research.

[59]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[60]  S. Gospe,et al.  Paraparesis, hypermanganesaemia, and polycythaemia: a novel presentation of cirrhosis , 2000, Archives of disease in childhood.

[61]  Hyunjoong Kim,et al.  Functional Analysis I , 2017 .

[62]  M. Beal,et al.  Determination of neurotransmitter levels in models of Parkinson's disease by HPLC-ECD. , 2011, Methods in molecular biology.

[63]  Human,et al.  A point mutation in TRPC 3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice , 2009 .

[64]  Altan Eşsizoğlu,et al.  [Chronic manganese intoxication due to methcathinone (ephedron) abuse: a case report]. , 2009, Turk psikiyatri dergisi = Turkish journal of psychiatry.

[65]  D. C. Henckel,et al.  Case report. , 1995, Journal.